Related Experiment Videos
SIRT1 gene polymorphisms affect the protein expression in cardiovascular diseases
Ulkan Kilic1, Ozlem Gok1, Ahmet Bacaksiz2
1Department of Medical Biology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
Certain single nucleotide polymorphisms (SNPs) in the SIRT1 gene are linked to cardiovascular disease (CVD) risk and altered SIRT1 and eNOS protein levels, impacting oxidative stress markers.
Area of Science:
- Genetics and Molecular Biology
- Cardiology
- Biochemistry
Background:
- Cardiovascular disease (CVD) is a leading global cause of mortality, influenced by gene-environment interactions and epigenetic factors.
- SIRT1 protein plays a crucial role in maintaining homeostasis and protecting against CVD-related damage.
- Epigenetic modifications, including single nucleotide polymorphisms (SNPs), are increasingly recognized as contributors to CVD pathogenesis.
Purpose of the Study:
- To investigate the association between specific SIRT1 gene polymorphisms (rs7895833, rs7069102, rs2273773) and CVD.
- To examine the correlation of these SIRT1 SNPs with SIRT1 and eNOS protein expression levels.
- To assess the relationship between SIRT1 SNPs and markers of oxidative stress: total antioxidant status (TAS), total oxidant status (TOS), and oxidative stress index (OSI) in CVD patients.
Main Methods:
- Genotyping of three SIRT1 SNPs (rs7895833, rs7069102, rs2273773) in CVD patients and control subjects.
- Measurement of SIRT1 and eNOS protein expression levels using relevant biochemical assays.
- Quantification of TAS, TOS, and OSI to evaluate oxidative stress status.
Main Results:
- Mutant genotypes and alleles for rs7069102 and rs2273773 were significantly more frequent in CVD patients, indicating a 2.4-fold and 1.9-fold increased CVD risk, respectively, associated with their mutant alleles.
- No significant association was found for rs7895833 SNP with CVD.
- CVD patients exhibited elevated SIRT1 protein, TAS, TOS, and OSI, but reduced eNOS protein levels compared to controls.
- Increased SIRT1 expression was observed in CVD patients with the mutant genotype for rs7069102 and heterozygote genotypes for all three SNPs.
Conclusions:
- SIRT1 gene polymorphisms, specifically rs7069102 and rs2273773, are associated with an increased risk of cardiovascular disease.
- These genetic variations correlate with altered SIRT1 and eNOS protein expression and dysregulated oxidative stress markers in CVD patients.
- This study provides novel insights into the interplay between SIRT1 genetics, protein expression, and oxidative stress in the context of cardiovascular disease.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Coronary Artery Disease I: Introduction
Pharmacogenetics of Drug Metabolism: Overview
Single Nucleotide Polymorphisms-SNPs